MEDICAL DEVICES & DIABETES CARE

Diabetic Patient Device Usability Satisfaction & Treatment Adherence Survey

Diabetic patients using insulin delivery, CGM, and self-monitoring devices evaluate, compare, and navigate usability barriers and adherence triggers daily, so you can sharpen device positioning, fix retention gaps, and benchmark satisfaction across patient segments.

Pan-India sample
Diabetic patients (Active Device Users)
15-20 min
Talk to a Survey Consultant
Adherence friction & drop-offsIdentify where patients abandon prescribed devices due to usability barriers.
Satisfaction drivers & segment gapsBenchmark satisfaction scores across device type, therapy stage, and diagnosis duration.
TRUSTED BY LEADING BRANDS
Brand 0Brand 1Brand 2Brand 3Brand 4Brand 5Brand 6Brand 7Brand 8Brand 9Brand 10Brand 11Brand 12Brand 13Brand 14Brand 15Brand 16Brand 17Brand 18Brand 19Brand 20Brand 21Brand 22Brand 23Brand 24Brand 25Brand 26Brand 27Brand 28Brand 29Brand 30Brand 31

CONTEXT & RELEVANCE

Why run this survey now

Most diabetes device makers don't lose patients purely on clinical efficacy. They lose adherence due to device discomfort, confusing titration interfaces, alert fatigue, poor onboarding support, and misaligned refill workflows, none of which fully show up in prescription data or post-market surveillance reports.

If you are...

  • CGM or insulin pump manufacturer

  • Digital therapeutics platform lead

  • Device portfolio strategy head

  • Patient engagement program director

  • Payer or formulary access team

You're likely facing...

  • Device discontinuation: usability vs cost

  • Adherence drop-off: titration stage

  • CGM = accurate/uncomfortable perception

  • Onboarding gaps: HCP vs self-managed

  • Refill lapse and switching triggers

This will help answer...

  • Usability drivers beyond clinical accuracy

  • Adherence drop-off stage and cause

  • Segment preference by device type

  • Willingness to pay vs feature trade-offs

  • Switching triggers and retention levers

RESEARCH THEMES

What This Survey Investigates

Eight interconnected research themes that map the complete diabetic patient journey from device onboarding to sustained treatment adherence.

TENETS 01

Device Discovery & Selection

  • Prescriber influence on device choice
  • First device category trialed
TENETS 02

Onboarding & Setup

  • Initial training format and source
  • Time-to-first-successful-use
TENETS 03

Usability & Ergonomics

  • Physical handling across patient profiles
  • Display readability and alert clarity
TENETS 04

Data & Connectivity

  • App pairing reliability and sync frequency
  • Data sharing with care team
TENETS 05

Adherence Friction

  • Missed doses and skipped readings
  • Lifestyle conflict with device routine
TENETS 06

Satisfaction & Switching

  • Net satisfaction by device category
  • Switch triggers and brand consideration
TENETS 07

Cost & Coverage

  • Out-of-pocket burden by device type
  • Insurance reimbursement gaps
TENETS 08

Support & Advocacy

  • Post-purchase support channel usage
  • Peer referral and community influence
Request a scope validation call

SAMPLING STRATEGY

Tell us about your ideal sample

Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.

Sample size
How many respondents do you need?
Not Selected
Target audience
Who should we survey?
Not Selected
Region
Which regions should we cover?
Not Selected
Segments
How should we slice the data?
Not Selected
Discuss sample plan

METHODOLOGY

Survey approach

For the Diabetic Patient Device Usability Satisfaction & Treatment Adherence Survey, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification across patient and caregiver segments.

PRIMARY
Online web surveySelf-administered survey shared via email / panels to capture structured responses at scale.
Best for
1
Measuring device usability satisfaction by device type
2
Ranking adherence barriers across therapy stages
3
Comparing segments by diagnosis duration and regimen
Deliverables
Usability satisfaction scores
Adherence barrier ranking
Segment comparison matrix
OPTIONAL
CATI (phone survey)Interviewer-led telephone interviews to reach owners who are harder to get online.
Best for
1
Elderly patients with low digital comfort
2
Reaching patients in Tier 2 and Tier 3 cities
Deliverables
Representative patient coverage
Call-log diagnostics
SELECTIVE
Face-to-faceOn-ground surveys or interviews in key industrial clusters or high-value cohorts.
Best for
1
Insulin-dependent patients requiring device demonstration
2
Caregivers managing complex multi-device regimens
Deliverables
Device interaction maps
Caregiver journey profiles
OPTIONAL
FGDs
Deliverables
Themes and quotes
Concept feedback
OPTIONAL
Mixed surveysAny 4-mode combo Online + CATI + F2F + FGDs to maximise reach and representation. Mode-specific quotas and weighting for clean comparisons.
Deliverables
Unified dataset
Mode-adjusted analytics
Our Recommendation
Start with: Online web survey as the core quant layer, supported by CATI for elderly and low-digital patient segments in Tier 2 and Tier 3 markets.
Consider adding: Face-to-face interviews for insulin-dependent and multi-device cohorts, plus a focused FGD layer to pressure-test device messaging and patient support program concepts.
Confirm approach
Request timeline

EXECUTION PROCESS

How we execute

A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.

Define the decision frame

Confirm objectives, target cohorts, geographies, and reporting cuts

Step 01

Define the decision frame

Design the instrument

Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)

Step 02

Design the instrument

Lock the questionnaire

Review wording, sequencing, LOI, and competitive context; approve final version

Step 03

Lock the questionnaire

Pilot and calibrate

Test comprehension and ease quality; refine quotas and remove friction where needed

Step 04

Pilot and calibrate

Run fieldwork

Execute collection with active quota management and feasibility controls

Step 05

Run fieldwork

Assure quality

Dedupe, attention checks, speed/consistency rules, removals with audit trail

Step 06

Assure quality

Prepare the dataset

Clean data and deliver codebook/variable definitions

Step 07

Prepare the dataset

Analyse and synthesise

Driver ranking, leakage diagnostics, pricing bands, segment insights

Step 08

Analyse and synthesise

Deliver and align

Executive deck (optional dashboard) and leadership readout with recommendations

Step 09

Deliver and align

COMMERCIAL TERMS

Request a Commercial Proposal

Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.

Select Sample Size

100

Geography

  • India
  • APAC (Singapore, Vietnam, Philippines, Indonesia, Australia, NZ, Japan, Thailand)
  • Middle East (UAE, KSA, Qatar, Bahrain, Oman, Kuwait)
  • North America (US, Canada)
  • Europe
  • Africa (South Africa, Kenya, Nigeria, Egypt, Algeria)
  • LATAM (Brazil, Mexico)

Select Mode of Survey

  • Online
  • CATI
  • Online FGD (5 people per FGD)
  • F2F

Length of the Interview

  • Select
  • 0-15
  • 16-20
  • 21-30
  • 31-45
  • 46-60
  • Custom
Indicative Estimate
  • Indian Rupee (INR)
  • United Arab Emirates Dirham (AED)
  • Afghan Afghani (AFN)
  • Albanian Lek (ALL)
  • Armenian Dram (AMD)
  • Netherlands Antillean Guilder (ANG)
  • Angolan Kwanza (AOA)
  • Argentine Peso (ARS)
  • Australian Dollar (AUD)
  • Aruban Florin (AWG)
  • Azerbaijani Manat (AZN)
  • Bosnia-Herzegovina Convertible Mark (BAM)
  • Barbadian Dollar (BBD)
  • Bangladeshi Taka (BDT)
  • Bulgarian Lev (BGN)
  • Bahraini Dinar (BHD)
  • Burundian Franc (BIF)
  • Bermudian Dollar (BMD)
  • Brunei Dollar (BND)
  • Bolivian Boliviano (BOB)
  • Brazilian Real (BRL)
  • Bahamian Dollar (BSD)
  • Bhutanese Ngultrum (BTN)
  • Botswana Pula (BWP)
  • Belarusian Ruble (BYN)
  • Belize Dollar (BZD)
  • Canadian Dollar (CAD)
  • Congolese Franc (CDF)
  • Swiss Franc (CHF)
  • Chilean Peso (CLP)
  • Chinese Yuan (CNY)
  • Colombian Peso (COP)
  • Costa Rican Colón (CRC)
  • Cuban Peso (CUP)
  • Cape Verdean Escudo (CVE)
  • Czech Koruna (CZK)
  • Djiboutian Franc (DJF)
  • Danish Krone (DKK)
  • Dominican Peso (DOP)
  • Algerian Dinar (DZD)
  • Egyptian Pound (EGP)
  • Eritrean Nakfa (ERN)
  • Ethiopian Birr (ETB)
  • Euro (EUR)
  • Fijian Dollar (FJD)
  • Falkland Islands Pound (FKP)
  • British Pound (GBP)
  • Georgian Lari (GEL)
  • Ghanaian Cedi (GHS)
  • Gibraltar Pound (GIP)
  • Gambian Dalasi (GMD)
  • Guinean Franc (GNF)
  • Guatemalan Quetzal (GTQ)
  • Guyanese Dollar (GYD)
  • Hong Kong Dollar (HKD)
  • Honduran Lempira (HNL)
  • Croatian Kuna (HRK)
  • Haitian Gourde (HTG)
  • Hungarian Forint (HUF)
  • Indonesian Rupiah (IDR)
  • Israeli New Shekel (ILS)
  • Iraqi Dinar (IQD)
  • Iranian Rial (IRR)
  • Icelandic Króna (ISK)
  • Jamaican Dollar (JMD)
  • Jordanian Dinar (JOD)
  • Japanese Yen (JPY)
  • Kenyan Shilling (KES)
  • Kyrgyzstani Som (KGS)
  • Cambodian Riel (KHR)
  • Comorian Franc (KMF)
  • South Korean Won (KRW)
  • Kuwaiti Dinar (KWD)
  • Cayman Islands Dollar (KYD)
  • Kazakhstani Tenge (KZT)
  • Lao Kip (LAK)
  • Lebanese Pound (LBP)
  • Sri Lankan Rupee (LKR)
  • Liberian Dollar (LRD)
  • Lesotho Loti (LSL)
  • Libyan Dinar (LYD)
  • Moroccan Dirham (MAD)
  • Moldovan Leu (MDL)
  • Malagasy Ariary (MGA)
  • Macedonian Denar (MKD)
  • Burmese Kyat (MMK)
  • Mongolian Tögrög (MNT)
  • Macanese Pataca (MOP)
  • Mauritian Rupee (MUR)
  • Maldivian Rufiyaa (MVR)
  • Malawian Kwacha (MWK)
  • Mexican Peso (MXN)
  • Malaysian Ringgit (MYR)
  • Mozambican Metical (MZN)
  • Namibian Dollar (NAD)
  • Nigerian Naira (NGN)
  • Nicaraguan Córdoba (NIO)
  • Norwegian Krone (NOK)
  • Nepalese Rupee (NPR)
  • New Zealand Dollar (NZD)
  • Omani Rial (OMR)
  • Panamanian Balboa (PAB)
  • Peruvian Sol (PEN)
  • Papua New Guinean Kina (PGK)
  • Philippine Peso (PHP)
  • Pakistani Rupee (PKR)
  • Polish Złoty (PLN)
  • Paraguayan Guaraní (PYG)
  • Qatari Riyal (QAR)
  • Romanian Leu (RON)
  • Serbian Dinar (RSD)
  • Russian Ruble (RUB)
  • Rwandan Franc (RWF)
  • Saudi Riyal (SAR)
  • Solomon Islands Dollar (SBD)
  • Seychellois Rupee (SCR)
  • Sudanese Pound (SDG)
  • Swedish Krona (SEK)
  • Singapore Dollar (SGD)
  • Saint Helena Pound (SHP)
  • Sierra Leonean Leone (SLL)
  • Somali Shilling (SOS)
  • Surinamese Dollar (SRD)
  • São Tomé and Príncipe Dobra (STD)
  • Syrian Pound (SYP)
  • Swazi Lilangeni (SZL)
  • Thai Baht (THB)
  • Tajikistani Somoni (TJS)
  • Turkmenistani Manat (TMT)
  • Tunisian Dinar (TND)
  • Tongan Paʻanga (TOP)
  • Turkish Lira (TRY)
  • Trinidad and Tobago Dollar (TTD)
  • New Taiwan Dollar (TWD)
  • Tanzanian Shilling (TZS)
  • Ukrainian Hryvnia (UAH)
  • Ugandan Shilling (UGX)
  • United States Dollar (USD)
  • Uruguayan Peso (UYU)
  • Uzbekistani Som (UZS)
  • Vietnamese Đồng (VND)
  • Vanuatu Vatu (VUV)
  • Samoan Tālā (WST)
  • Central African CFA Franc (XAF)
  • East Caribbean Dollar (XCD)
  • West African CFA franc (XOF)
  • CFP Franc (XPF)
  • Yemeni Rial (YER)
  • South African Rand (ZAR)
  • Zambian Kwacha (ZMW)
  • Zimbabwean Dollar (ZWL)

$0.00

+ applicable taxes

Proposal turnaround typically 24–48 hours

Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.

REFERENCE CASELETS

Reference

Real-world examples of survey work in the diabetic care device and treatment adherence space.

CASELET 1

Insulin delivery device preference & switching triggers (India)

CASELET 2

Continuous glucose monitor onboarding & dropout diagnosis (South Asia)

Insulin delivery device preference & switching triggers (India)

OBJECTIVE

A specialty pharma brand needed to map how Type 2 insulin-dependent patients chose between prefilled pens and vial-and-syringe regimens , and which device handling barriers drove mid-therapy switches or abandonment.

WHAT WE DID

Ran a structured quant survey across 420 patients in 6 metros and Tier 2 cities, capturing device selection criteria, dose-setting confidence, injection site discomfort frequency, and caregiver involvement at each stage of the injection routine.

DELIVERED

A device friction map by patient segment, a ranked list of handling barriers by therapy stage , a switching trigger framework linking device dissatisfaction to prescriber re-consultation, and a set of message territories for the patient-facing field force.
Talk to Survey Consultant
CASELET 1

Insulin delivery device preference & switching triggers (India)

CASELET 2

Continuous glucose monitor onboarding & dropout diagnosis (South Asia)

Insulin delivery device preference & switching triggers (India)

OBJECTIVE

A specialty pharma brand needed to map how Type 2 insulin-dependent patients chose between prefilled pens and vial-and-syringe regimens , and which device handling barriers drove mid-therapy switches or abandonment.

WHAT WE DID

Ran a structured quant survey across 420 patients in 6 metros and Tier 2 cities, capturing device selection criteria, dose-setting confidence, injection site discomfort frequency, and caregiver involvement at each stage of the injection routine.

DELIVERED

A device friction map by patient segment, a ranked list of handling barriers by therapy stage , a switching trigger framework linking device dissatisfaction to prescriber re-consultation, and a set of message territories for the patient-facing field force.

FREQUENTLY ASKED QUESTIONS

Common Questions

Answers to frequently asked questions about this survey mandate.

What decisions will this survey enable?

Who is the buyer vs who are the respondents?

Can we see differences between insulin-dependent patients, non-insulin-dependent patients and newly diagnosed patients?

How will you measure device usability preference beyond simple ratings?

Will the survey map the full diabetes device adoption journey and drop-offs?

Can this survey inform product and pricing strategy?

How will findings improve our patient engagement and commercial launch strategy?

Still have questions?

Schedule a discovery call to discuss your specific needs and get a custom quote.

Book a Discovery Call